![James McCullough](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James McCullough
Gründer bei
RENALYTIX PLC
Vermögen: 99 660 $ am 31.05.2026
Profil
James Renwick McCullough is the founder of Renalytix Plc, founded in 2018, where the title held is Chief Executive Officer & Director.
Mr. McCullough is also the founder of Paige.
AI, Inc...
Current jobs include Chairman at BalletNext, Inc., Director at The Bonnie J.
Addario Lung Cancer Foundation, Director at Kantaro Biosciences LLC, Director at Renalytix AI, Inc., and Director at Go2 Foundation For Lung Cancer.
Former jobs include Chief Executive Officer at Exosome Diagnostics, Inc. from 2008 to 2014, Director at Quentra Networks, Inc., Director at Ausam Biotechnologies, Inc., Director at TAVEC Pharmaceuticals, Non-Executive Director at Verici Dx Plc from 2020 to 2026, Independent Non-Executive Director at LungLife AI, Inc. from 2019 to 2024, and Managing Partner at Renwick Capital LLC from 2014 to 2021.
Education includes undergraduate studies at Boston University and an MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RENALYTIX PLC 0,78 % | 12.02.2026 | 3 430 096 ( 0,78 % ) | 83 214 $ | 31.05.2026 |
VERICI DX PLC 0,19 % | 31.12.2024 | 2 870 110 ( 0,19 % ) | 16 446 $ | 31.05.2026 |
Aktive Positionen von James McCullough
| Unternehmen | Position | Beginn |
|---|---|---|
| RENALYTIX PLC | Gründer | 15.03.2018 |
BalletNext, Inc.
 BalletNext, Inc. Internet Software/ServicesTechnology Services Operates as a crossing platform creating collaborations between artists, students and institutions | Vorsitzender | - |
The Bonnie J. Addario Lung Cancer Foundation
 The Bonnie J. Addario Lung Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a philanthropy devoted to eradication Lung Cancer | Direktor/Vorstandsmitglied | - |
Kantaro Biosciences LLC
 Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Develops diagnostic test kits | Direktor/Vorstandsmitglied | - |
Renalytix AI, Inc. | Direktor/Vorstandsmitglied | - |
Go2 Foundation For Lung Cancer
 Go2 Foundation For Lung Cancer Go2 Foundation For Lung Cancer is a national nonprofit organization focused on confronting lung cancer through education, support, advocacy, and research. The private company is based in Washington, DC. The foundation provides resources on lung cancer types, risk factors, symptoms, diagnosis, staging, and treatment options such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biomarker testing, and clinical trials. It promotes early detection through lung cancer screening with low-dose CT scans and supports a national network of centers of excellence for lung cancer care. The organization offers personalized assistance via a free helpline, peer support programs, online social groups, coping skills workshops, and educational events. Go2 Foundation advances lung cancer research through initiatives like the lung cancer registry and partnerships with research institutes, and advocates for increased research funding, improved healthcare access, and reduced stigma. Community engagement is encouraged through fundraising, advocacy campaigns, awareness events, and sharing personal stories. Educational materials are provided in multiple formats and languages. The CEO of the company is Laurie Fenton Ambrose. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von James McCullough
| Unternehmen | Position | Ende |
|---|---|---|
| VERICI DX PLC | Direktor/Vorstandsmitglied | 31.03.2026 |
| LUNGLIFE AI, INC. | Direktor/Vorstandsmitglied | 24.10.2024 |
Renwick Capital LLC
 Renwick Capital LLC Investment ManagersFinance Provides investment services | Corporate Officer/Principal | 01.01.2021 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von James McCullough
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Quentra Networks, Inc.
 Quentra Networks, Inc. Specialty TelecommunicationsCommunications Sells wholesale long distance services | Communications |
LungLife AI, Inc.
 LungLife AI, Inc. Medical SpecialtiesHealth Technology Develops early detection solutions for lung cancer | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ausam Biotechnologies, Inc.
 Ausam Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biophysics and physiology research and development services | Commercial Services |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a philanthropy devoted to eradication Lung Cancer | Commercial Services |
Paige.Ai, Inc.
 Paige.Ai, Inc. Packaged SoftwareTechnology Services Operates as an AI company specializing in digital pathology | Technology Services |
Renalytix Plc
 Renalytix Plc Packaged SoftwareTechnology Services Provides artificial intelligence for kidney disease | Technology Services |
TAVEC Pharmaceuticals
 TAVEC Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops novel drugs pharm | Health Technology |
Renwick Capital LLC
Renwick Capital LLC Investment ManagersFinance Provides investment services | Finance |
BalletNext, Inc.
BalletNext, Inc. Internet Software/ServicesTechnology Services Operates as a crossing platform creating collaborations between artists, students and institutions | Technology Services |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Develops diagnostic test kits | Health Technology |
Renalytix AI, Inc. | Health Services |
Verici Dx Plc
 Verici Dx Plc Medical/Nursing ServicesHealth Services Provides kidney transplantation services | Health Services |
Go2 Foundation For Lung Cancer
Go2 Foundation For Lung Cancer Go2 Foundation For Lung Cancer is a national nonprofit organization focused on confronting lung cancer through education, support, advocacy, and research. The private company is based in Washington, DC. The foundation provides resources on lung cancer types, risk factors, symptoms, diagnosis, staging, and treatment options such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biomarker testing, and clinical trials. It promotes early detection through lung cancer screening with low-dose CT scans and supports a national network of centers of excellence for lung cancer care. The organization offers personalized assistance via a free helpline, peer support programs, online social groups, coping skills workshops, and educational events. Go2 Foundation advances lung cancer research through initiatives like the lung cancer registry and partnerships with research institutes, and advocates for increased research funding, improved healthcare access, and reduced stigma. Community engagement is encouraged through fundraising, advocacy campaigns, awareness events, and sharing personal stories. Educational materials are provided in multiple formats and languages. The CEO of the company is Laurie Fenton Ambrose. |
